Cargando…
P108 Obstructive Sleep Apnoea in Acute Coronary Syndrome: An Observational Study
Obstructive sleep apnoea (OSA) is a risk factor for cardiovascular disease. CPAP therapy is the primary treatment for OSA and is known to improve long term cardiovascular health outcomes. Recent neutral findings of randomised clinical trials have created uncertainty about whether effective CPAP ther...
Autores principales: | Tong, B, Dissanayake, H, Patel, S, Ucak, S, Skilton, M, McClintock, S, Sutherland, K, Yee, B, Sarkissian, N, Cistulli, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591751/ http://dx.doi.org/10.1093/sleepadvances/zpad035.193 |
Ejemplares similares
-
P107 Optimizing Obstructive Sleep Apnea Therapy in Patients with Acute Coronary Syndrome: A Pilot Randomised Controlled Trial
por: Tong, B, et al.
Publicado: (2023) -
O037 Diagnostic Accuracy of OSA Screening Tools for Acute Coronary Syndrome
por: Tong, B, et al.
Publicado: (2023) -
O004 Obstructive sleep apnoea severity is associated with parasympathetic withdrawal in coronary artery disease
por: Ucak, S, et al.
Publicado: (2021) -
P095 Heart Rate Variability during Sleep in Paroxysmal Atrial Fibrillation patients with and without Obstructive Sleep Apnoea
por: Mohammadieh, A, et al.
Publicado: (2021) -
P151 Short-term mandibular advancement splint therapy for Obstructive Sleep Apnoea improves parasympathetic modulation
por: Ucak, S, et al.
Publicado: (2021)